About Luo Feng
Luo Feng is an executive officer and director at Vesicor Therapeutics.
Luo Feng first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Luo Feng in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Luo Feng works with at each company, as listed on that company's latest Form D.
Vesicor Therapeutics, Inc. · Form D, May 14, 2025
MB
Michael Bowen
Chief Financial Officer
WH
Warren Jr. Hosseinion
Executive officer
OL
Oded Levy
Director
WH
Warren Hosseinion
Director